The Differentiated Introduction of Generic Drugs in Francophone and Anglophone West African Countries: An Illustration of Drug Globalization Based on the Case of Benin (notice n° 453532)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 02013cam a2200277 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250121031658.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Baxerres, Carine |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | The Differentiated Introduction of Generic Drugs in Francophone and Anglophone West African Countries: An Illustration of Drug Globalization Based on the Case of Benin |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2013.<br/> |
500 ## - GENERAL NOTE | |
General note | 18 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Based on the case of Benin, this paper describes recent changes that have occurred in the field of international pharmaceuticals in West Africa: legal recognition of generic drugs, development of the pharmaceutical industry in “emerging” countries, and competition with Western multinational corporations. The introduction of generic drugs in West African countries occurs in different ways, and there are significant differences in the national pharmaceutical legislations between Francophone and Anglophone countries. Importers, distributors, prescribers, and consumers in Anglophone countries have been more open to generic drugs and supplies from “emerging” countries from the outset. This has had a very positive impact in terms of access to medicines, but raises a number of public health issues. The flexibility of the liberal distribution that accompanies these phenomena creates a loss of control by healthcare professionals. Beyond the legal differences between countries, products circulate, and delivery practices tend to homogenize, illustrating the current globalization of medications. |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | regulation |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | consumption |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | French-speaking countries |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | pharmaceuticals |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | distribution |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | Benin |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | globalization |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | Western Africa |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | English-speaking countries |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | generic drugs |
786 0# - DATA SOURCE ENTRY | |
Note | Autrepart | o 63 | 4 | 2013-05-17 | p. 51-68 | 1278-3986 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-autrepart-2012-4-page-51?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-autrepart-2012-4-page-51?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux